These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1578664)

  • 21. [The eyes of chronic uremic patients treated with an artificial kidney].
    Perrin D; Vantelon J; Man MK; Zingraff J
    Annee Ther Clin Ophtalmol; 1970; 21():87-100. PubMed ID: 5525939
    [No Abstract]   [Full Text] [Related]  

  • 22. Intranasal deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
    Shapiro MD; Kelleher SP
    Am J Nephrol; 1984; 4(4):260-1. PubMed ID: 6332534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anemia associated with chronic renal failure and chronic dialysis.
    Hodgson S
    Nephrol Nurse; 1980; 2(3):43-6. PubMed ID: 6900910
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased risk of malignancy and blood-membrane interactions in uraemic patients.
    Akizawa T; Kinugasa E; Koshikawa S
    Nephrol Dial Transplant; 1994; 9 Suppl 2():162-4. PubMed ID: 8065609
    [No Abstract]   [Full Text] [Related]  

  • 26. [Amino acids supplementation therapy in uremic patients on regular blood purification treatment].
    Ando A
    Nihon Rinsho; 2004 May; 62 Suppl 5():384-8. PubMed ID: 15197950
    [No Abstract]   [Full Text] [Related]  

  • 27. [High-molecular compounds in the erythropoietic disorder of patients in the terminal stage of chronic kidney failure].
    Gudim VI; Sukiasova TG; Ivanova VS; Gorbunova NA; Kozinets GI
    Patol Fiziol Eksp Ter; 1985; (6):66-71. PubMed ID: 4094808
    [No Abstract]   [Full Text] [Related]  

  • 28. [Risk factors and cardiovascular disease in uremic patients].
    Valdés F; Morales JM
    Nefrologia; 2002; 22 Suppl 4():1-6. PubMed ID: 12123136
    [No Abstract]   [Full Text] [Related]  

  • 29. Regional vs "tight" heparinization in hemodialysis.
    Lee JH; Cocke TB; Gonzalez FM
    Proc Clin Dial Transplant Forum; 1974; (4):239-47. PubMed ID: 4549633
    [No Abstract]   [Full Text] [Related]  

  • 30. Uremic neuropathy. A case presentation.
    Alter SA; Mendicino S
    J Am Podiatr Med Assoc; 1991 Oct; 81(10):559-61. PubMed ID: 1663549
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effects of heparin-free dialysis on uremic hyperlipidemia in patients on maintenance hemodialysis. I. The change of lipids during a dialysis (author's transl)].
    Matsui N; Iwamoto H; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J; Sasaoka T; Shoji T
    Nihon Jinzo Gakkai Shi; 1980 Nov; 22(11):1437-46. PubMed ID: 6782282
    [No Abstract]   [Full Text] [Related]  

  • 32. [Kinetics of anticoagulation in hemodialysis. Sequential study of single, intermittent and continuous heparinization].
    Ghezzi PM; Di Siena F; Palanca R; Dutto A; Cento G
    Minerva Med; 1980 Oct; 71(41):2987-91. PubMed ID: 7454084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
    Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
    J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shortening of bleeding time after intranasal administration of 1-deamino-8-D-arginine vasopressin to patients with chronic uremia.
    Rydzewski A; Rowiński M; Myśliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):823-30. PubMed ID: 2436997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uremia.
    Meyer TW; Hostetter TH
    N Engl J Med; 2007 Sep; 357(13):1316-25. PubMed ID: 17898101
    [No Abstract]   [Full Text] [Related]  

  • 36. Control of bleeding in severely uremic patients undergoing oral surgery.
    Buckley DJ; Barrett AP; Koutts J; Stewart JH
    Oral Surg Oral Med Oral Pathol; 1986 Jun; 61(6):546-9. PubMed ID: 2941716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The heart in end-stage renal failure: etiology, symptoms and management of uremic heart disease.
    Contrib Nephrol; 1986; 52():1-149. PubMed ID: 3568665
    [No Abstract]   [Full Text] [Related]  

  • 38. [Uremic pericarditis. Study of 24 cases].
    Rivera Hernández F; Alvarez Chiva V; Sánchez Crespo M; Casado Pérez S; Hernando Avendaño L
    Rev Clin Esp; 1980 Oct; 159(2):115-8. PubMed ID: 7209033
    [No Abstract]   [Full Text] [Related]  

  • 39. [Uremic hemorrhagic pericarditis in chronic hemodialysis patients (apropos of 5 cases)].
    Alquati P; Domenichelli B; Castagneto M; Cestari R; Ronzoni G
    Chir Patol Sper; 1972 Dec; 20(5):350-72. PubMed ID: 4205870
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and pathophysiological aspects of neurological complications in renal failure.
    De Deyn PP; Saxena VK; Abts H; Borggreve F; D'Hooge R; Marescau B; Crols R
    Acta Neurol Belg; 1992; 92(4):191-206. PubMed ID: 1332359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.